News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
872,238 Results
Type
Article (88123)
Company Profile (825)
Press Release (783270)
Multimedia
Podcasts (203)
Webinars (29)
Section
Business (233327)
Career Advice (4151)
Deals (39890)
Drug Delivery (152)
Drug Development (91464)
Employer Resources (205)
FDA (18422)
Job Trends (17437)
News (398070)
Policy (39989)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3021)
Academic (2)
Accelerated approval (37)
Adcomms (36)
Allergies (158)
Alliances (56982)
ALS (185)
Alzheimer's disease (1820)
Antibody-drug conjugate (ADC) (364)
Approvals (18613)
Artificial intelligence (659)
Autoimmune disease (185)
Automation (45)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (210)
Biotechnology (490)
Bladder cancer (168)
Brain cancer (67)
Breast cancer (688)
Cancer (5224)
Cardiovascular disease (464)
Career advice (3575)
Career pathing (42)
CAR-T (316)
CDC (65)
Celiac Disease (2)
Cell therapy (864)
Cervical cancer (39)
Clinical research (77264)
Collaboration (1904)
Company closure (5)
Compensation (1218)
Complete response letters (78)
COVID-19 (3000)
CRISPR (105)
C-suite (940)
Cystic fibrosis (155)
Data (6520)
Decentralized trials (2)
Denatured (75)
Depression (159)
Diabetes (547)
Diagnostics (7288)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (323)
Drug pricing (227)
Drug shortages (36)
Duchenne muscular dystrophy (251)
Earnings (100495)
Editorial (68)
Employer branding (25)
Employer resources (174)
Events (135547)
Executive appointments (1062)
FDA (21737)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1607)
Gene editing (226)
Generative AI (71)
Gene therapy (698)
GLP-1 (1150)
Government (5472)
Grass and pollen (8)
Guidances (388)
Healthcare (20971)
HIV (70)
Huntington's disease (51)
IgA nephropathy (89)
Immunology and inflammation (307)
Immuno-oncology (71)
Indications (122)
Infectious disease (3311)
Inflammatory bowel disease (216)
Inflation Reduction Act (17)
Influenza (130)
Intellectual property (265)
Interviews (817)
IPO (17967)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (71)
Kidney cancer (18)
Labor market (97)
Layoffs (662)
Leadership (42)
Legal (10166)
Liver cancer (99)
Longevity (17)
Lung cancer (706)
Lymphoma (393)
Machine learning (45)
Management (66)
Manufacturing (899)
MASH (180)
Medical device (15073)
Medtech (15135)
Mergers & acquisitions (23021)
Metabolic disorders (1450)
Multiple sclerosis (174)
NASH (23)
Neurodegenerative disease (375)
Neuropsychiatric disorders (108)
Neuroscience (3209)
Neurotech (1)
NextGen: Class of 2026 (7709)
Non-profit (5120)
Now hiring (69)
Obesity (706)
Opinion (343)
Ovarian cancer (172)
Pain (222)
Pancreatic cancer (245)
Parkinson's disease (310)
Partnered (39)
Patents (538)
Patient recruitment (525)
Peanut (63)
People (67092)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23873)
Phase 2 (33529)
Phase 3 (25251)
Pipeline (5682)
Policy (350)
Postmarket research (3554)
Preclinical (10710)
Press Release (72)
Prostate cancer (257)
Psychedelics (60)
Radiopharmaceuticals (310)
Rare diseases (969)
Real estate (7443)
Recruiting (81)
Regulatory (29258)
Reports (69)
Research institute (2738)
Resumes & cover letters (652)
Rett syndrome (28)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (265)
Series B (205)
Service/supplier (30)
Sickle cell disease (107)
Special edition (28)
Spinal muscular atrophy (178)
Sponsored (49)
Startups (4337)
State (2)
Stomach cancer (21)
Supply chain (115)
Tariffs (101)
The Weekly (126)
Vaccines (1184)
Venture capital (101)
Weight loss (485)
Women's health (102)
Worklife (22)
Date
Today (169)
Last 7 days (743)
Last 30 days (2599)
Last 365 days (32812)
2026 (4550)
2025 (33229)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (94)
Alaska (7)
Arizona (351)
Arkansas (15)
Asia (51651)
Australia (9074)
California (11952)
Canada (3424)
China (1209)
Colorado (506)
Connecticut (521)
Delaware (360)
Europe (118785)
Florida (1773)
Georgia (385)
Hawaii (4)
Idaho (68)
Illinois (995)
India (78)
Indiana (564)
Iowa (24)
Japan (454)
Kansas (135)
Kentucky (45)
Louisiana (30)
Maine (84)
Maryland (1494)
Massachusetts (8777)
Michigan (372)
Minnesota (678)
Mississippi (6)
Missouri (144)
Montana (36)
Nebraska (29)
Nevada (130)
New Hampshire (87)
New Jersey (3207)
New Mexico (33)
New York (3150)
North Carolina (1660)
North Dakota (10)
Northern California (5759)
Ohio (367)
Oklahoma (23)
Oregon (55)
Pennsylvania (2381)
Puerto Rico (25)
Rhode Island (51)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4624)
Tennessee (183)
Texas (1879)
United States (43056)
Utah (358)
Vermont (1)
Virginia (301)
Washington D.C. (88)
Washington State (1000)
West Virginia (4)
Wisconsin (137)
Wyoming (2)
There are 872,238 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rare disease
FDA’s Bespoke Pathway To Focus on Gene Editing and RNA-Based Treatments for Rare Diseases
The framework, first introduced by FDA Commissioner Marty Makary and Center for Biologics Evaluation and Research head Vinay Prasad in November, was criticized for lacking detailed guidance. Agency leaders elucidated on the pathway for personalized medicines on Monday.
February 23, 2026
·
3 min read
·
Nick Paul Taylor
Executive appointments
Merck Reorganizes Human Health Work Into Two New Units
The new structure will help Merck as it slides toward a loss of exclusivity for Keytruda, pharma’s best-selling drug.
February 23, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space
February 23, 2026
·
9 min read
Government
Kennedy Ally Departs CDC Amid Leadership Shake-Up
Ralph Abraham, a vocal vaccine skeptic who served at the agency for just three months, has stepped down due to “unforeseen family obligations,” according to the CDC.
February 23, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Coherus Oncology to Participate in Upcoming March 2026 Investor Conferences
February 23, 2026
·
1 min read
Press Releases
Jupiter Neurosciences Amends Yorkville Installment Provisions to Align Capital With Clinical and Commercial Execution
February 23, 2026
·
3 min read
Press Releases
Transactions in Connection with Share Buy-back Program
February 23, 2026
·
3 min read
Press Releases
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
February 23, 2026
·
4 min read
Press Releases
Volta Labs and Watchmaker Genomics Partner to Introduce Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026
February 23, 2026
·
3 min read
Press Releases
Neutrolis Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors as Executive Director
February 23, 2026
·
3 min read
1 of 87,224
Next
